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Abstract
Congenital long QT syndrome is a heritable family of arrhythmias caused by mutations in 13 genes encoding ion channel
complex proteins. Mounting evidence has implicated the Purkinje fiber network in the genesis of ventricular arrhythmias. In
this study, we explore the hypothesis that long QT mutations can demonstrate different phenotypes depending on the
tissue type of expression. Using computational models of the human ventricular myocyte and the Purkinje fiber cell, the
biophysical alteration in channel function in LQT1, LQT2, LQT3, and LQT7 are modeled. We identified that the plateau
potential was important in LQT1 and LQT2, in which mutation led to minimal action potential prolongation in Purkinje fiber
cells. The phenotype of LQT3 mutation was dependent on the biophysical alteration induced as well as tissue type. The
canonical DKPQ mutation causes severe action potential prolongation in both tissue types. For LQT3 mutation F1473C,
characterized by shifted channel availability, a more severe phenotype was seen in Purkinje fiber cells with action potential
prolongation and early afterdepolarizations. The LQT3 mutation S1904L demonstrated striking effects on action potential
duration restitution and more severe action potential prolongation in Purkinje fiber cells at higher heart rates. Voltage
clamp simulations highlight the mechanism of effect of these mutations in different tissue types, and impact of drug
therapy is explored. We conclude that arrhythmia formation in long QT syndrome may depend not only on the basis of
mutation and biophysical alteration, but also upon tissue of expression. The Purkinje fiber network may represent an
important therapeutic target in the management of patients with heritable channelopathies.
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Introduction
Congenital long QT syndrome (LQTS) is a heritable family of
arrhythmias caused by mutations in 13 genes encoding ion
channel complex proteins[1]. These mutations exert their effect
through altered ion channel gating and/or trafficking, resulting in
prolongation of action potential duration (APD). This prolonga-
tion manifests as lengthening of the QT interval on the
electrocardiogram, providing an electrophysiological substrate
for arrhythmia formation. While the majority of the characteriza-
tion of arrhythmias in this disorder to date has involved the
ventricular myocyte (VM), mounting evidence implicates the
cardiac specialized conduction system, comprised of the Purkinje
fiber (PF) network, as a particularly important trigger of
arrhythmias[2–6]. PF cells (PFC) have distinctive action potential
(AP) characteristics, including the property of automaticity, longer
APD, and lower plateau membrane potential[7]. Each of these
features may uniquely predispose these cells to arrhythmia
formation.
Mathematical modeling has been employed to simulate genetic
and acquired channelopathies and assay their effects on cardiac
tissue[8,9]. We have recently developed comprehensive integrative
models of the electrophysiology of both the human VM[10] and
PFC[11]. By virtue of their biophysically detailed Markov
representations of ion channels (constrained to data obtained
from human ion channels in heterologous expression), these
models are well-suited to the study of LQT mutations, through
targeted modification of the processes responsible for channel
dysfunction.
In this study, we create models of LQTS in VM and PFC to
investigate the hypothesis that LQTS-related mutations may
manifest their phenotype in a tissue-specific manner. Several
disease-causing mutations are simulated in each cardiac tissue
type. We demonstrate that arrhythmia formation in LQTS may
depend not only upon the specific mutation and biophysical
alteration but also upon the tissue of expression, supporting an
important role for the PFC.
Results
LQT1 and LQT2 mutations have a mild phenotype in PFC
As LQT1 and LQT2 mutations often result in complete loss-of-
function of the affected KCNQ1 or HERG allele, respectively
(through defective trafficking or biophysical changes in channel
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function)[1], idealized heterozygous mutations were simulated by
reducing peak conductance of IKs or IKr by 50% to simulate
heterozygous LQT1 or LQT2, respectively. Figure 1 shows the
resulting APs obtained at 1 Hz stimulation frequency. Heterozy-
gous LQT1 mutation prolonged APD by only 8 ms in PFC, in
contrast to VM, in which a 36 ms APD prolongation is seen.
Mutation in LQT2 prolongs PFC APD by 28 ms and VM APD by
46 ms. Clinically, homozygous LQT1 mutation leads to the
Jervell-Lange-Nielsen syndrome[1], which is characterized by
severe QT prolongation. Homozygous LQT1, simulated as IKs
deletion, results in further prolongation of VM APD (408 ms
versus 304 ms WT), which is in stark contrast to the PFC APD
which exhibits minimal prolongation of 15 ms.
The differential degree of APD prolongation in PFCs compared
to VMs is only partially explained by differences in baseline IKr
and IKs current density. IKr shows a 60% lower whole cell peak
conductance in PFC, but IKs whole cell peak conductance is 60%
greater. The lower plateau potential in PFC plays a large role in
the tissue-specific response via less complete activation of IK
channels. IKs channel isochronal 1000 ms open probability at the
PFC plateau potential measures 0.22, compared with 0.82 at the
VM plateau potential.
Different potential mechanisms of arrhythmia formation
in Andersen-Tawil Syndrome
The Andersen-Tawil Syndrome (ATS, or LQTS type 7[12]) is
linked to heterozygous loss of function in Kir2.1, which encodes
the inward rectifier current IK1, through defective channel
trafficking[13]. Previous work demonstrates that with dominant
negative suppression of IK1 current, delayed afterdepolarizations
(DADs) are observed in simulated VM[14], and that a PFC focus
may be responsible for this arrhythmia[15].
In Figure 2, dominant negative IK1 suppression is simulated in
both VM and PFC. Arrhythmias occur via different mechanisms
in the two cell types. In the VM model, progressive downregu-
lation of IK1 leads to DADs of increasing amplitude occurring
immediately after the AP (panel A), until another AP is triggered
leading to repetitive membrane depolarization. The mechanism is
identical to that observed in guinea pig VM[14]. Analogous
downregulation of IK1 in PFC shows no DADs (panel B). The
slow diastolic depolarization underlying PFC automaticity reaches
threshold for AP formation earlier than in VM, with a less
polarized maximum diastolic potential. The result is an approx-
imate doubling of the intrinsic firing rate stemming from
unopposed HCN current. Our simulations show that VM carrying
ATS mutations are capable of triggered activity as an arrhythmic
mechanism, while corresponding PFC show no DADs but display
enhanced automaticity, another potential mechanism for arrhyth-
mia.
Effect of the SCN5A sodium channel mutations on PFC
and VM
SCN5A inactivation defects underlie AP prolongation in LQT3
via gain of function, producing a persistent component of INa
termed late current, or INaL. These defects can occur as a result of
alteration of several distinct biophysical processes. Using several
different mutations in SCN5A, we explored whether these
alterations may manifest in a tissue- and/or mutation-specific
manner.
The first studied and most thoroughly characterized mutant,
DKPQ, results in channels that enter a ‘bursting’ mode of gating:
channel entry into this mode of gating is rare, but recovery from
this mode is infrequent, trapping the channel in a state in which it
cannot inactivate[8]. This results in time-invariant persistent
channel opening, which generates inward late current that
prolongs APD. Given the lower plateau potential in PFC, and
consequent larger driving force for INa entry, our initial
hypothesis was that a more pronounced effect of DKPQ would
be seen on the PFC APD compared with VM.
Figure 3 shows the resulting APs using a rate constant for the
bursting transition that produces 0.5% persistent current, corre-
sponding to previous studies[8,16]. At 1 Hz, APD is prolonged by
69% and 61% in VM and PFC, respectively. After a 2 second
pause, VM APD carrying the mutation is prolonged to 866 ms
(increase of 185%), compared to PFC at 892 ms (increase of
146%). Similarly, more severe APD prolongation is noted in both
tissue types during bradycardia (pacing at 30 BPM and 40 BPM,
panels C and D), as summarized in Figure 4E.
The finding that VM are more affected by DKPQ than PFC
was surprising, since in PFC there is a larger driving force for
sodium entry during the plateau. We hypothesized that the more
depolarized diastolic potential in PFC may force a larger fraction
of SCN5A channels into unavailable states, preventing entry into
the pathologic bursting states.
Therefore, we next tested the role of channel availability by
simulating the LQT3 SCN5A mutation F1473C, a mutation
characterized clinically by severe QT interval prolongation and
heavy arrhythmia burden[17], and characterized biophysically by
a rightward shift in the availability curve of 10 mV and large
amplitude late current. F1473C channels were simulated with the
Figure 1. Differential response of VM (panel A) and PF (panel B) to mutation in IKs and IKr channels, leading to LQT1 and LQT2,
respectively. Compared to wild type (WT, black trace), heterozygous LQT1 (blue trace) and LQT2 (red trace), modeled as a 50% reduction in whole
cell conductance, VM APs are prolonged, while PF are mildly affected. Homozygous LQT1 (100% reduction in IKs conductance, dashed blue trace)
leads to substantial APD prolongation in VM, and trivial further prolongation in PF.
doi:10.1371/journal.pone.0097720.g001
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same bursting rate as DKPQ, along with a shift in the availability
curve of 10 mV in the depolarized direction (see expanded
methods for values of rate constants)[18]. Figure 4 shows APs at
1 Hz, demonstrating marked APD prolongation (598 ms in VM
versus 677 ms in PFC). As with DKPQ, following a 2 sec pause,
APD is prolonged for both tissue types. Strikingly, for PFC
following a pause, repetitive early afterdepolarization (EAD)
formation is observed as a result of severe APD prolongation.
Similar findings are observed for continuous pacing at slower
rates. For PFC at 40 BPM, there is a single EAD in every other
beat (AP alternans, seen in panel D), while at 30 BPM APs with an
EAD alternate with shorter APs. These findings clearly establish
an arrhythmogenic substrate within PFC for the F1473C
mutation.
S1904L mutation in SCN5A confers a more severe
phenotype in PFC than VM through a different channel
gating mechanism
In contrast to typical SCN5A LQT3 mutations, for which the
phenotype is exacerbated by bradycardia and rest, the SCN5A
S1904L LQTS mutation was described in a young patient with
only a mildly prolonged QT interval who developed palpitations
with mild exercise[9]. We have recently characterized these
mutant channels, which exhibit late current as a result of late
channel reopenings without a bursting component.
This channel behavior is recapitulated by reducing the
inactivation rate constant and reducing the rate constant of entry
into deeper buried inactivated states by a factor of 5 and 6,
respectively, generating 0.28% late current (as seen experimental-
ly[9]). Figure 5A shows the predicted consequence of the S1904L
in the VM model. As previously shown at 1 Hz[9], the impact on
VM is minimal (no prolongation). In contrast, PFC bearing this
mutation exhibit 120 ms APD prolongation at 1 Hz. More rapid
pacing (120 BPM) exacerbates this phenotype, prolonging PFC
APD by 200 ms but still with minimal change in VM. The result is
a markedly flattened restitution curve for the PFC model even with
a mild increase in rate. A predominant rate-dependent effect on
PFC explains the emergence of the clinical phenotype with
exercise as well as the propensity for arrhythmia formation despite
minimal QT interval prolongation.
Voltage clamp simulations reveal mechanism of
mutation-specific differences in LQT3
The differential response of the PFC AP to DKPQ and F1473C
suggests that the shift in channel availability (proarrhythmic) may
counteract the effect of hyperpolarized diastolic potential in PFC
(antiarrhythmic). To directly test the contributions of these factors
individually, voltage clamp simulations were performed at
different holding potentials (2100 mV and 280 mV, correspond-
ing to the diastolic potential of VM and PFC, respectively) with
steps to different test potentials (+20 and 0 were selected,
corresponding to plateau potentials). Absolute late sodium current
at 100 ms was calculated, alongside percent persistent current
(normalized to peak) for WT, DKPQ, and F1473C. At a holding
potential of 2100 mV, both DKPQ and F1473C show similar
amounts of late current, regardless of step potential (and driving
force), in contrast to WT cells (first two sets in Figure 6A). At a
holding potential of 280 mV, F1473C exhibits a far greater late
current than DKPQ. Lesser late current is produced by DKPQ at
depolarized resting potentials due to gating of channels into
unavailable states (top row of states in Figure 1B of Clancy[19])
from which they cannot burst nor conduct current during the
plateau of the AP. Thus, the higher driving force for current entry
is counterbalanced by lower fractional occupancy of bursting states
that carry INaL. When availability is shifted in F1473C channels,
direct comparison of the -100 to +20 mV simulation (mimicking a
VM AP profile) and 280 to 0 mV simulation (mimicking a PFC
AP profile) shows more absolute late current in the PFC-like
profile. This substantial increase in late current underlies the more
severe prolongation of APD in PFCs for the F1473C mutation.
We also used the square voltage clamp protocol for the S1904L
mutation to mimic VM and PFC AP morphologies. In the ‘‘VM-
like’’ voltage clamp, the magnitude of the late current (and late
current fraction) is small compared to the PFC-like voltage clamp
profile (see Figure 6B). The prolonged time course of inactivation
at 0 mV compared to +20 mV (time constant of current decay
67 ms at 0 mV versus 30 ms at +20 mV) confers a larger
functional impact in the context of the S1904L mutation, allowing
persistent channel opening during the step potential. This
corresponds to 85% smaller net summed current entry (net
charge) during the test pulse for a VM-like profile (bar graph,
Figure 6B). Repetition of these voltage clamp waveforms at 2 Hz
does not appreciably alter net current entry, suggesting that the
larger effect at higher frequencies in PFC is due to smaller
Figure 2. Arrhythmias in Andersen-Tawil syndrome, modeled as dominant negative suppression of IK1 current, have different
mechanisms in VM (panel A) versus PF (panel B) myocytes. For VM, compared to WT (black trace) reduction of IK1 conductance by 90% (blue)
leads to a large delayed afterdepolarization. Further reduction to 95% (red) increases the size of the DAD, triggering repetitive action potentials. For
PF, reduction of IK1 conductance maximum diastolic potential is less polarized, leading to increased automaticity. Unstimulated PF APs show basic
cycle length of automaticity of 2250 msec, which decreases to 1260 with 90% IK1 reduction.
doi:10.1371/journal.pone.0097720.g002
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counterbalancing net repolarizing current such as the transient
outward current.
Discussion
The major findings of this study are that a) LQT1 and LQT2
exert a relatively mild phenotype in PFC; b) different mechanisms
of arrhythmia formation are seen in Andersen-Tawil syndrome
based on cardiac tissue type; c) the canonical LQT3 mutant
DKPQ has severe phenotype in both VM and PFC tissue types; d)
in contrast to DKPQ, the LQT3 mutant F1473C shows a
particularly severe phenotype in PFC with repetitive membrane
depolarizations due to shifted availability of sodium channels; and
e) the LQT3 mutant S1904L exerts a mild phenotype, but is more
severe in PFC with strong rate-dependent exacerbation of
phenotype. Numerous lines of evidence implicate the PF system
as important in the genesis of LQTS-related arrhythmias,
including findings from electrophysiological studies of affected
patients. Our findings, which stem from inherent differences in the
Figure 3. VM and PFC carrying the SCN5A DKPQ mutation exhibit similarly severe APD prolongation. Panel A and B) Effect of a 2
second pause for VM and PFC, respectively, compared with 1000 msec (last beat of drive train shown for WT, black trace, and mutant cells, blue
trace). Panels C and D) Steady state rate adaptation for VM and PFC, respectively (30 BPM: blue trace, 40 BPM: red trace, 60 BPM: black trace). E)
Summary results for APD prolongation for each cell type for different stimulus protocols; VM: black bars, PF: gray bars.
doi:10.1371/journal.pone.0097720.g003
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electrophysiology of the PFC compared to the VM, provide a
theoretical basis with which to understand these clinical observa-
tions.
Arrhythmias in the ATS may result from enhanced PFC
automaticity
The mechanism of arrhythmia formation in ATS has not been
established. Previous simulation studies showed that in VM with
dominant negative suppression of IK1, DADs were ob-
served[14,20]. Our findings in VM reproduce this behavior, with
repetitive membrane depolarization upon critical IK1 reduction
(Figure 3). PFC with dominant negative IK1 suppression,
however, did not show evidence of DADs. Instead, we saw a
graded increase in intrinsic automaticity. This suggests that
abnormal automaticity (stemming from the cardiac conduction
system) and/or triggered activity (from VM) may underlie the
ventricular arrhythmias seen in ATS. The Sanders lab has
reported sharp ‘‘Purkinje potentials’’ preceding ventricular
premature beats during electrophysiology studies in ATS pa-
tients[15]. The bidirectional ventricular tachycardia often seen in
these patients may reflect alternation between two different PFC
foci with enhanced automaticity, via a mechanism similar to that
described by Weiss[21]. Our results thus provide a plausible
mechanism that may underlie the clinical demonstration of His-
Purkinje system involvement.
The importance of the plateau potential in determining
APD for LQT1 and LQT2
In all mutations studied, one common theme is the importance
of the plateau potential (and plateau current magnitudes) in
determining the effect of a mutation. Our results simulating LQT1
and LQT2 (Figure 1) show a more profound APD-prolonging
effect of IK deletion in VM. It has been widely reported that
baseline IK density is different in VM and PFC[22], and as such,
the dependence on IK for membrane repolarization (and
consequence of deletion of these currents) would be expected to
be different in each cell type. However, we found that differences
in channel activation may underlie the greater APD prolongation
in VM. Indeed, at the VM plateau potential, our results predict a
nearly four-fold greater IKs channel open probability. Previous
experiments using APs as command waveforms predicted a similar
result, wherein larger IK current was elicited using an AP with
ventricular morphology[23]. Taken together, these results suggest
that not only channel density, but AP shape regulates the effect of
LQT1 and LQT2 mutations in different tissue types.
Our model for LQT1 was relatively simple, in that a simple
change in conductance was simulated rather than a more subtle
loss-of-function resulting from altered kinetics. Pourrier and Nattel
reported that accessory subunits of the IKs channel may express
differentially in different cardiac tissue types, with a higher density
in Purkinje fibers[24]. A disproportionate reduction in PFC IKs
via differential expression of subunits may modulate the predic-
tions of the simpler model described herein.
Figure 4. Differential effect on APD for VM versus PF of the SCN5A F1473C mutation. Panels A and B) Effect of a 2 second pause for VM
and PFC, respectively, compared with 1000 msec (last beat of drive train shown for WT, black trace, and mutant cells, blue trace). APD in the F1473C
shows pause-dependent increase, with spontaneous oscillations in membrane potential from sequential early afterdepolarizations seen post-pause
for PF but not VM. Panels C and D) Rate adaptation for VM and PFC, respectively (30 BPM: blue trace, 40 BPM: red trace, 60 BPM: black trace. In VM
cells, substantial APD prolongation is seen (on the order of that seen with DKPQ mutation) with pronounced bradycardia dependence. In PF APs,
severe APD prolongation is seen at 60 BPM, for 40 BPM stable alternans are seen (with a small early afterdepolarization on every other beat), and at 30
BPM the membrane fails to repolarize.
doi:10.1371/journal.pone.0097720.g004
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Altered Na+ channel availability and defects in
inactivation modulate tissue-specific effects of LQT3
mutations
Clancy[8] showed that AP prolongation with the DKPQ
deletion in SCN5A can arise from sodium channels that enter
an abnormal bursting mode, in which the channel is trapped in a
configuration from which it cannot transition to inactivate.
We initially hypothesized that for PFC carrying DKPQ, a larger
driving force for sodium current entry during the relatively
hyperpolarized plateau provides the basis for more severe APD
prolongation. We did not find this to be the case, instead observing
a slightly more pronounced APD prolongation in VM compared
to PFC. The steady-state availability curve for SCN5A predicts
0.68 fractional availability at the PFC diastolic potential of 2
83 mV and 0.85 fractional availability at the corresponding VM
potential of 291 mV. The additional fraction of inactivated
channels in PFC cannot transition into the bursting states to
produce persistent current.
Our previous work described the LQT3 mutation F1473C,
characterized by severe QT prolongation that is further exacer-
bated by bradycardia and substantial late sodium current[18].
When implemented into the PFC model, the results indicate that
the shift in availability seen with F1473C compensates for the
relatively depolarized resting potential seen in this tissue type.
With the consequent greater availability of mutant channels, the
enhanced driving force for sodium current entry in PFC causes
disproportionate prolongation of APD. Moreover, we demon-
strated in this study that PFC are prone to EADs, the putative
cellular triggers of ventricular arrhythmia, and stable AP alternans
promoted by slow pacing rates. These findings suggest that
disruption of PFC electrophysiology was responsible for the
affected patient’s unusually heavy burden of ventricular arrhyth-
mia clinically, which required defibrillator implantation as a
neonate[17] and which improved markedly upon faster pac-
ing[25].
Our finding that channel steady-state availability impacts
channel function in a tissue-specific manner led us to explore
whether our results have important implications for drug therapy.
We tested two different local anesthetic drugs, flecainide (modeled
as a charged local anesthetic SCN5A blocker) and lidocaine
(modeled as an uncharged local anesthetic SCN5A blocker which
affects channel availability) on our PFC model of F1473C. In the
drug free state, severe APD prolongation is seen along with
multiple EADs, particularly in response to a 2 second pause.
Flecainide was modeled as a 20% block in sodium current and
lidocaine as a 20% block in sodium current plus a leftward shift of
the availability curve of SCN5A. We identified that with lidocaine,
the availability shift of lidocaine conferred greater efficacy in terms
of APD shortening and abolishing EADs (unlike flecainide). These
simulations raise the intriguing possibility that drug efficacy may
vary in a tissue-specific manner in LQTS patients.
The LQT3 mutation S1904L is unique in that APD prolon-
gation and ventricular arrhythmias occur with faster heart rates
(unlike in DKPQ or F1473C). Furthermore, arrhythmias occurred
with mild exercise in the proband carrying this mutation[9]. Our
previous characterization of this mutation showed minimal effect
on ventricular APD at physiological pacing frequencies (although
an effect was measurable at .200BPM[9]). In our current study,
we show that VM exhibit minimal change in AP duration at both
60BPM and 120BPM, whereas for PFC a more pronounced effect
is seen. Via this mechanism, a heterogeneous repolarization
substrate emerges preferentially at higher heart rates, explaining
the propensity toward arrhythmia formation during exercise.
Impact of concomitant repolarizing current blockade on
LQTS phenotype
Given its relatively slow activation, IK in cardiac cells is thought
to play a larger role under conditions that cause AP prolongation.
Acquired LQTS, as occurs via partial blockade of IKr associated
with QT-prolonging drug therapy, may reflect unmasking of a
subclinical channelopathy, through deletion of an important
repolarizing influence that in WT cells may be redundant. As
studied by Gintant in canine Purkinje fibers[26], AP prolongation
from repolarizing current blockade may manifest prominently in
PF. Since there are known difficulties in estimating the values of
IK density in VM, and this density may vary from cell to cell, we
explored whether variation in IK in cells carrying LQT3
mutations may affect our findings. As shown in Figure S3 in File
S1, we found that concomitant IK block leads to substantial AP
prolongation in VM carrying LQT3 mutations (both DKPQ and
F1473C), but no EADs are seen even with IK block up to 50%.
This suggests that while repolarizing currents play a larger role in
the presence of coincident gain-of-function LQTS mutations, it is
the degree of late current augmentation that determines whether
triggered activity occurs.
We furthermore performed simulations in another model of the
human ventricular action potential, and with both epicardial and
endocardial profiles, to establish that our findings in LQT3
generalize across tissue layer and do not reflect artifactual behavior
unique to one ionic model of the ventricular myocyte. For these
simulations (described in further detail in File S1), the model of
Figure 5. The S1904L mutation, characterized clinically by
arrhythmia at low levels of exertion, simulated at clinically
relevant pacing frequencies. The mutation exhibits minimal
response in VM (panel A, traces overlap) and greater APD prolongation
in PF (panel B), with APD alternans seen at 120 BPM (lower row). WT
cells: black trace, S1904L: blue trace.
doi:10.1371/journal.pone.0097720.g005
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Ten Tusscher[27] was utilized. The findings confirm those
obtained using the model described here (Figure S4 in File S1).
Nature of the interaction between PFC and VM impacts
arrhythmogenesis at the organ level and potential
therapeutic strategies
The cell type-specific responses to different LQTS mutations
theoretically provide a substrate for arrhythmogenesis, by increas-
ing the heterogeneity of repolarization (contributing to dispersion
of APD and dispersion of the QT interval). Evidence is
accumulating that the PF network is organized in complex sheets
adjacent to the endocardial surface of the heart that only interact
with VM at sparse PFC-VM junctions. This geometry may
facilitate propagation of EADs that occur preferentially and focally
in PFC to neighboring cell layers, suggesting the potential for
reentry and proarrhythmia.
Antiarrhythmic therapy is the standard of care in the
management of many patients with LQTS, with an adjunctive
role of implantable cardioverter-defibrillators to reduce mortality
associated with sudden cardiac death. A central role of the PFC
and specialized conduction system may suggest specific pharma-
cologic targets that may be tailored to a specific mutation.
Furthermore, since PFC can be targeted anatomically, alternate
modes of therapy, for example, via catheter ablation may be
possible. We have recently characterized a PFC-specific mutation
in the transient outward current, identified in patients with
idiopathic ventricular fibrillation who were successfully treated
with catheter ablation[28]. Since the His-Purkinje system inserts
endocardially, PF triggers in other heritable channelopathies may
evolve to represent attractive targets of ablation therapy, as has
recently been reported in a canine model of LQT3[29] and during
electrophysiology studies of patients with LQTS[2].
Limitations
A first limitation of the simulations shown is that conclusions
apply to the single cell, but without multicellular analysis, its
impact on the whole organ level remains untested. Future work by
Figure 6. Voltage clamp protocols demonstrate the mechanism of late current generation in LQT3 mutations. Panel A illustrates the
voltage clamp waveform used. Panel B demonstrates the important role of resting membrane potential and plateau potential on degree of late
sodium current in DKPQ (red bar) and F1473C mutations (blue bar) compared to WT (black bar). For a ‘‘VM-like’’ voltage clamp protocol (holding 2
100 mV, step potential 20 mV, top row), similar persistent current is seen for KPQ and F1473C mutations. When holding potential is changed to 2
80 mV mimicking PF AP resting potential, second row, persistent current is less for the KPQ mutation than for the F1473C mutation (which has
increased availability at this potential). Third and fourth rows show the individual effect of altering plateau and resting potentials. Panel C) Response
of step potentials simulating VM (black) and PF (blue) in cells carrying the S1904L mutation. The ‘‘PF-like’’ voltage clamp waveform produces more
inward current at all time points, leading to more accumulated inward charge as demonstrated below in the bar graph.
doi:10.1371/journal.pone.0097720.g006
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our group will explore the potential for triggering of arrhythmias
from these cellular proarrhythmic states.
A second limitation lies in the formulation of calcium handling
utilized. This is a weakness of every current model of the PFC. We
plan to update our model to incorporate what is known about PFC
ultrastructure and more accurately reflect intracellular calcium
cycling. Such an addition may further elucidate the link between
altered membrane repolarization and triggers of arrhythmia.
Conclusions
The Purkinje fiber network has long been implicated as a source
of ventricular arrhythmia. We show that for several mutations
linked to LQTS, a different phenotype emerges in different
cardiac tissue types, often predicting a more severe phenotype in
PFC. Our findings suggest the potential for a new type of
regulation of heritable channelopathies in which not only channel
dysfunction but the variable impact on different cardiac tissues can
modulate the severity of phenotype, with important implications
for therapy of these conditions.
Methods
The whole-cell mathematical models utilized in this study have
been described previously[10,11]. Briefly, these models are
composed of systems of coupled nonlinear differential equations
representing channel occupancies, which are integrated numeri-
cally using a fourth order Runge-Kutta ordinary differential
equations solver with an adaptive time-step. Computations were
performed in C++ language on a 4-processor workstation,
allowing single cell computations in real time. Further details
regarding the computational models can be found in previous
work[10,11].
The previously developed PFC model[11] is implemented
without change. In order to model the mutations identically in
each tissue type, the Markov representations of membrane
currents from the VM model were replaced with the correspond-
ing models from the PFC, specifically the slow component of the
delayed rectifier potassium current (IKs) and the fast sodium
current INa[11]. To ensure appropriate balance of densities of the
fast component of the delayed rectifier IK (IKr) and IKs after this
change, conductance of these currents was adjusted to produce
appropriate response of APD to specific blockers of each
component (E-4031 for IKr[30] and chromanol 293B for
IKs[31]). Appropriate APD for human epicardial VM was
reproduced, chiefly through a 20% increase in the conductance
of the L-type calcium current (matching recent data recording L-
type current density in human right[32] and left[33–35] VM). A
complete description of model parameters is provided in the
expanded methods section in the File S1. The model reproduces
key features of human epicardial VM, including appropriate rate
dependent shortening of APD, as seen in Figure S1 in File S1. In
Figure S2 in File S1 the updated model output is compared to a
recorded action potential and the original model of Iyer et al [10],
showing minimal difference in action potential shape and
duration.
Source code for the two utilized models is provided in the
supplementary material online (Source Code S1).
Supporting Information
File S1 This file contains Figure S1–Figure S4, Table S1,
and Table S2. Figure S1, Action potentials for VM (panel A) and
PF (panel B) at 0.5 Hz (dash-dot), 1 Hz (dashed), and 2 Hz (solid)
stimulation frequency. Features unique to PF APs include lower
plateau potential, prolonged APD, and slow diastolic depolariza-
tion (automaticity). Figure S2, Panel A) Simulated original Iyer
model[3] action potential obtained at 1 Hz pacing (black trace)
versus that of the model with update described in Methods (blue
trace). Panel B) Human left ventricular epicardial action potential
recorded at 1 Hz from Nabauer[1] compares favorably to the
model output. Figure S3, Simulated drug block of IK in cells
carrying LQT3 mutations shows minimal additional AP prolon-
gation in PF cells carrying the DKPQ mutation (panel A)
compared to VM (panel B). WT: gray trace, DKPQ: solid black,
DKPQ with 50% IKs block: gray dashed, DKPQ with 50% IKr
block: black dashed. Panel C) For the F1473C mutation in VM,
substantial concomitant block of IK (50% reduction) fails to
produce EADs in the post-pause beat, which are seen during drug-
free simulations of PF cells. F1473C: solid, F1473C with 50% IKs
block: gray dashed, F1473C with 50% IKr block: black dashed.
Figure S4, Use of an alternate model of the human ventricular
action potential, that of Ten Tusscher[4], shows a similar response
to LQT3 mutations. Top row: Epicardial (panel A) and
endocardial (panel B) ventricular cell models are utilized to study
wild type (WT, black trace), DKPQ (red trace) and F1473C
mutant sodium channels following a 2 second pause This VM
model shows no evidence of early afterdepolarization formation
matching findings in Figures 3 and 4. In Panel C, bradycardia is
simulated with 40 BPM pacing in an epicardial cell, also
demonstrating no early afterdepolarizations, similar to findings
from the modified Iyer model[3]. Panel D) The S1904L mutation
simulated in the Ten Tusscher model at 2 Hz (red trace) shows
superimposed action potentials over wild type (WT, black trace),
similar to Figure 5. Table S1, Changes to the original human
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